A flow cell assay for evaluation of whole cell drug efflux kinetics: Analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein
Jt. Lin et al., A flow cell assay for evaluation of whole cell drug efflux kinetics: Analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein, DRUG META D, 29(2), 2001, pp. 103-110
P-glycoprotein (Pgp) mediates drug accumulation defects in malignant cells
in vitro. It confers resistance to multiple drugs including paclitaxel, an
agent useful in treating malignancies including acute leukemia. Pgp-mediate
d drug resistance appears to be due to primary active drug-transport as wel
l as other effects on membrane permeability, but the relative contribution
of each is unclear. Flow cells are useful for differentiating transport-med
iated efflux from altered membrane permeability, but their utility is limit
ed to attached cells. We developed a novel flow cell to study drug efflux k
inetics in suspension culture cells and examined paclitaxel efflux in resis
tant CEM/VLB100 leukemia cells, which overexpress Pgp, compared with its se
nsitive CEM parent line. Paclitaxel efflux from both cell lines was describ
ed by bi-exponential kinetics. The predominant initial rapid component incr
eased linearly with paclitaxel concentration, consistent with passive efflu
x, and was faster in CEM/VLB100 than CEM cells. The slow terminal component
of efflux was also more rapid for CEM/VLB100 than CEM, and was saturable (
V-max = 9.1 +/- 1.1 versus 3.5 +/- 0.3 pmol/min/10(7) cells, respectively)
at a lower paclitaxel concentration than the parental CEM cells (k(m) = 63
+/- 46 nM versus 144 +/- 56 nM, respectively). In CEM/VLB100 cells, this sa
turable component was inhibited by verapamil and was temperature-sensitive,
consistent with Pgp-mediated transport. Verapamil also inhibited the rapid
component of efflux, suggesting additional effects on membrane permeabilit
y. Our studies show that the present technique is useful for studying drug
transport and that effects of Pgp on membrane permeability contribute signi
ficantly to the net drug-accumulation defect.